Robert Baltera Insider Profile
4 Followers
Robert Baltera, Director at Palisade Bio, holds 461.90K shares in Palisade Bio (Ticker: PALI), holds 0.00 shares in Imago BioSciences (Ticker: IMGO), holds 138.51K shares in VivoSim Labs (Ticker: VIVS). Most recently, Robert Baltera Bought ― shares of Palisade Bio on Jul 10, 2026 for an estimated value of $88.35K.
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
-2.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert Baltera holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Baltera
Robert Baltera's Trading History
Palisade Bio
Jul 10, 2026
Director
Informative Buy
88.35K
$970.00K
VivoSim Labs
Aug 19, 2016
Director
Uninformative Buy
―
$39.61K
Imago BioSciences
Jan 11, 2023
―
Uninformative Sell
30.60K
$0.00
NewAmsterdam Pharma Company
―
Director
―
―
Xencor
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Robert Baltera's performance on stock
You May Also Like
Robert Baltera insider profile FAQ
What is the percentage of profitable transactions made by Robert Baltera?
The percentage of profitable transactions made by Robert Baltera is 80%.
What is the average return per transaction made by Robert Baltera?
The average return per transaction made by Robert Baltera is -2.30%.
What stocks does Robert Baltera hold?
Robert Baltera holds: PALI, VIVS, IMGO, NAMS, XNCR stocks.
What was Robert Baltera’s latest transaction?
Robert Baltera latest transaction was an Informative Buy of $88.35K.
What was Robert Baltera's most profitable transaction?
Robert Baltera’s most profitable transaction was an Informative Buy of PALI stock on July 10, 2026. The return on the trade was 7.10%.
What is Robert Baltera's role in Palisade Bio?
Robert Baltera's role in Palisade Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.